117 KENDRICK STREET, NEEDHAM, MA
Market cap: $469.8M (12/18/2025)
Price: $7.76
Announces Strategic Transition Plan to Accelerate Next Phase of Growth
PART II INFORMATION NOT REQUIRED IN PROSPECTUS
Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
Verastem Oncology Reports Positive Preliminary Results from VS-7375 Trial in KRAS G12D Mutant Solid Tumors
Updated Data on GFH375 for KRAS G12D Mutant Pancreatic Cancer by Verastem Oncology and GenFleet
Delivering Novel Therapies for RAS/MAPK Pathway Driven Cancers Presentation | September 2025
Verastem Oncology's Late-Breaking Study on GFH375 for Lung Cancer at IASLC 2025
R&D Investor Event ASCO 2025 June 2, 2025
Q2
Q1
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Notice of Proposed Sale of Securities
Free Writing Prospectus